Biphasic insulin aspart 30 treatment improves glycemic control among patients with type 2 diabetes in Saudi Arabia and the Gulf region

被引：0
|
作者：
Ayad, Nasrat M. [1 ]
Fattah, Waleed A. [2 ]
Bakry, Hani [2 ]
机构：
[1] Taiba Hosp, Dept Internal Med, Kuwait, Kuwait
[2] Novo Nordisk Gulf, Dept Med, Riyadh, Saudi Arabia
来源：
SAUDI MEDICAL JOURNAL | 2008年 / 29卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：919 / 920
页数：2
相关论文
共 50 条
  • [31] Biphasic insulin aspart and biphasic human insulin in type 2 diabetes: A comparison
    Jacobsen, LV
    Bell, PM
    McSorely, P
    Kristensen, A
    DIABETES, 2000, 49 : A112 - A112
  • [32] Transferring patients with type 2 diabetes no longer controlled with basal human insulin to biphasic insulin aspart 30 leads to improved control
    Barbonta, Diana H.
    Mocan, Emiliana
    Yeo, Jing Ping
    DIABETES, 2008, 57 : A562 - A563
  • [33] Biphasic insulin aspart 30 improves treatment results in patients with early type 2 diabetes poorly controlled on prior diabetes treatment: Preliminary results from the PRESENT study
    Lee, Inkyu
    Lee, So Ra
    Lebedev, Nikolay
    Kedijang, Timothy
    Tuna, Sebnem
    Hassan, Ayman
    Shinde, Anil
    Yeo, Jing Ping
    Yap, Charlotte
    DIABETES, 2007, 56 : A567 - A567
  • [34] Biphasic insulin aspart 30 treatment in patients with type 2 diabetes poorly controlled on prior diabetes treatment: results from the PRESENT study
    Sharma, S. K.
    Al-Mustafa, M.
    Oh, S. J.
    Azar, S. T.
    Shestakova, M.
    Guler, S.
    Vaz, J. A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (03) : 645 - 652
  • [35] Intensifying Insulin Therapy from Basal Insulin to Biphasic Insulin Aspart (BIAsp 30) Improves Glucose Control and Treatment Satisfaction in Patients with Type 2 Diabetes: South Korea Subgroup of IMPROVE™ Study
    Kim, Chong Hwa
    Jeong, Su Jin
    Mok, Ji Oh
    Ryu, Ohk Hyun
    Lee, Kiyoung
    Jeong, In Kyung
    Lee, Byung Wan
    Kim, Hyun Jin
    Lee, Sora
    Kim, Sun Woo
    DIABETES, 2010, 59 : A566 - A566
  • [36] Effect of biphasic insulin aspart on glucose and lipid control in patients with Type 2 diabetes mellitus
    Lalic, N. M.
    Antic, Micic S.
    Bajovic, L.
    Pantelinac, P.
    Jotic, A.
    Kendereski, A.
    Dimic, D.
    Djukic, A.
    Mitrovic, M.
    Vujasin, M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (17) : 2895 - 2901
  • [37] In inadequately controlled patients with Type 2 diabetes, Biphasic Insulin Aspart 30 combined with Pioglitazone provides better glycaemic control than Biphasic Insulin Aspart 30 monotherapy or Pioglitazone/Sulphonylurea combination.
    Raz, I
    Stranks, S
    Filipczak, R
    Joshi, P
    Lertoft, B
    Råstam, J
    Chow, FC
    DIABETOLOGIA, 2003, 46 : A8 - A8
  • [38] Insulin degludec/insulin aspart vs biphasic insulin aspart 30 twice daily in Japanese patients with type 2 diabetes: A randomized controlled trial
    Onishi, Yukiko
    Yamada, Kenichi
    Zacho, Jeppe
    Ekelund, Jan
    Iwamoto, Yasuhiko
    JOURNAL OF DIABETES INVESTIGATION, 2017, 8 (02) : 210 - 217
  • [39] Biphasic insulin aspart 30 plus metformin: an effective combination in type 2 diabetes
    Kvapil, A
    Swatko, A
    Hilberg, C
    Shestakova, A
    DIABETES OBESITY & METABOLISM, 2006, 8 (01): : 39 - 48
  • [40] Comparison of biphasic insulin aspart and human insulin premix in patients with Type 2 diabetes
    Itoh, Hiroshi
    Morikawa, Akizuki
    Asai, Mahito
    Nishimura, Hideo
    Atoh, Keita
    Mutou, Eiji
    Oshima, Eiji
    Iwashima, Yasunor-I
    Miura, Takanori
    Sekiguchi, Masatomo
    Tani, Mitsunori
    Haneda, Masakazu
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 : S65 - S65
12345